http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
방사선 요오드-131의 국소주입에 의한 양성 갑상선 결절의 치료
제갈영종(Young Jong Jaegal),범희승(Hee Seoung Boom),윤정한(Jung Han Yoon),임동표(Dong Pyo Lim),하일주(Il Joo Ha) 대한두경부종양학회 2001 대한두경부 종양학회지 Vol.17 No.2
Background and Objective: Percutaneous ethanol injection therapy has been used in the treatment of the benign thyroid diseases. Although the reported side-effects of the therapy was mild and transient, some side-effects including local or radiating pain are troublesome to the patients. Radioactive iodine-131( Ra?131I) also has been effectively and safely used for management of the benign thyroid diseases. So we developed the percutaneous intranodular injection therapy of Ra?131I as an alternative of percutaneous ethanol injection therapy. Materials and Methods: From December 1998 to October 1999, we treated 29 outpatients (25 women and 4 men, mean age: 47±12 years). Inclusion criteria were follows; age >30 years, cytologically benign, with normal thyroid function, cold nodule on thyroid scintigram, solid or mixed natured nodules in sonographical evaluation. Nodular volume was estimated by sonography according to the ellipsoid formula. Ra?131I (0.1mCi/ml) was administered in a single dose injection. Follow-up studies every 3 months consisted of full history, thyroid function test, and sonography. We determined the therapeutic response is effective if the volume reduction of the nodule occurred above 30%. Results: After at least 3 months follow-up, 11 patients showed effective response, 12 patients showed minimal or unchanged response and 6 patients showed progression. Although side-effects such as injection pain, febrile reaction, and hormonal changes were absent, an infectious complication in injection site was developed from 1 case. Conclusion: Although we need a more prolonged follow-up to evaluate the delayed sequelae, we can suggest that percutaneous intranodular injection therapy of Ra?131 I may be an attractive non-surgical treatment in selected cases of benign thyroid nodules.
박종훈(Jong Hoon Park),강효(Hyo Kang),조문형(Mun Hyeong Cho),윤정한(Jung Han Yoon),제갈영종(Young Jong Jaegal),박민호(Min Ho Park) 대한두경부종양학회 2006 대한두경부 종양학회지 Vol.22 No.1
Granular cell tumor is not rare and is a well recognized entity which has a wide anatomic distribution, with roughly one half of the lesions found in the head and neck. However, occurrence in the thyroid is extremely rare and has not been described well as surgeon's view. The authors have recently experienced a case of multifocal granular cell tumor of the thyroid in a 26-year-old women presented with painless mass in the anterior neck area and fatigue. So, we present this case with the review of literatures.
김세종(Sae Jong Kim),김재휴(Jae Hwu Kun),제갈영종(Young Jong Jaegal),윤정한(Jung Han Yoon) 대한두경부종양학회 1996 대한두경부 종양학회지 Vol.12 No.2
갑상선 유두암에 의한 뇌전이는 극히 드물게 발견되어며 그 진단 및 치료방법의 설정이 아직 확립되어 있지 못한 상태이다. 저자들은 갑상선 유두암으로 5년전 갑상선 전절제술을 시술받고 갑상선 호르몬 복용을 하고 있던 24세의 남자에서 간헐적인 발작을 일으킨 전두골내 병소가 갑상선 유두암의 전이에 의한 것임을 조직학적으로 확인할 수 있었다. 이 병소는 전신 요오드 주사상에서는 나타나지 않았지만 Brain CT 및 MRI 소견으로만 병변의 진단이 가능하였으며 stereotactic cranitomy에 의한 종양제거로 비교적 만족스러운 결과를 얻어 현재 밀착추적중에 있다. Brain metastasis is extremely rare in thyroid papillary carcinoma which has an indolent clinical course and results in good prognosis. A 24-year-old man presenting with seizure attack is described. He had been treated under the diagnosis of thyroid papillary carcinoma with total thyroidectomy, postoperative internal radiation with radioactive iodine, and thyroid hormone replacement. Although 99m Tc brain spect and 131 I whole body scan did not revealed any significant lesion, brain CT and MRI showed lcm sized mass in frontal lobe. Stereotactic craniotomy and removal of the tumor, which was histologically proven metastatic lesion from thyroid papillary carcinoma, was done with satisfactory improvement.
고위험군 유두상 갑상선암 환자에 대한 방사성옥소 최대허용선량 측정법 및 치료법의 검증
김정철,윤정한,제갈영종,범희승<SUP>1<.SUP>,Jung Chul Kim,M.D.,Jung Han Yoon,M.D.,Young Jong Jaegal,M.D. and Hee Seung Bum,M.D.<SUP>1<.SUP> 대한갑상선-내분비외과학회 2002 The Koreran journal of Endocrine Surgery Vol.2 No.2
Purpose: Radioiodine (I-131) therapy is an effective modality to reduce both recurrence and mortality rates in differentiated thyroid cancer. Whether higher doses shows higher therapeutic responses was still debatable. The purpose of this study was to validate curve-fitting (CF) method measuring maximum permissible dose (MPD) by a biological dosimetry using metaphase analysis of peripheral blood lymphocytes. Methods: Therapeutic effects of MPD was also evaluated in 58 patients (49 females and 9 males, mean age 50⁑11 years) of papillary thyroid cancer. Among them 43 patients were treated with ≤7.4 GBq, while 15 patients with ≥9.25 GBq. The former was defined as low-dose group, and the latter high-dose group. Therapeutic response was defined as complete response when complete disappearance of lesions on follow-up I-131 scan and undetectable serum thyroglobulin levels were found. Statistical comparison between groups were done using chi-square test. P value less than 0.05 was regarded as statistically significant. Results: MPD measured by CF method using tracer and therapeutic doses were 13.3⁑1.9 and 13.8⁑2.1 GBq, respectively (P=0.20). They showed a significant correlation (r=0.8, P<0.0001). Exposed doses to blood measured by CF and biological methods were 1.54⁑0.03 and 1.78⁑0.03 Gy (P=0.01). They also showed a significant correlation (r=0.86, P=0.01). High-dose group showed a significantly higher rate of complete response (12/15, 80%) as compared to the low-dose group (22/43, 51.2%) (P=0.05). While occurrence of side effects was not different between two groups (40% vs. 30.2%, P=0.46). Conclusions: measurement of MPD using CF method is reliable, and the high-dose I-131 therapy using MPD gains significantly higher therapeutic effects as compared with low-dose therapy. (Korean J Endocrine Surg 2002;2:97-104)
여포성 종양을 동반한 침윤성 리들씨 갑상선염 (Riedel's Thyroiditis) 1예
박민호(Min Ho Park),제갈영종(Young Jong Jaegal),윤정한(Jung Han Yoon),조문형(Mun Hyeong Cho),강효(Hyo Kang),박종훈(Jong Hoon Park) 대한두경부종양학회 2006 대한두경부 종양학회지 Vol.22 No.1
Riedel's thyroiditis is an uncommon disorder of unknown etiology that is characterized by an invasive process that partially destroys the gland and extends into adjacent neck structures. Its clinical manifestation as a stonyhard, poorly defined enlargement over the thyroid gland and local compression of the trachea, esophagus and recurrent laryngeal nerve can mimic invasive thyroid carcinoma and mask the accompanied thyroid neoplasm. A case of Riedel's thyroiditis in a 59-year-old female patient, admitted with a previous diagnosis of adenomatous goiter, is reported. So, we present this case with the review of literatures.